MedTrace Logo

Study to Assess Clinical Response of Duloxetine in Patients Hospitalized for Severe Depression

NCT02229825 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 339

Last updated 2023-10-23

Study results available
· View outcomes & findings →

Summary

Study to assess efficacy of Duloxetine 120 mg and Duloxetine 60 mg in patients hospitalized for severe depression after 4 weeks of treatment. To evaluate the rescue option in non-responding patients. Safety of Duloxetine will also be assessed.

Conditions

  • Depressive Disorder, Major

Interventions

DRUG

Duloxetine

Capsule

DRUG

Placebo

Capsule

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-09
Primary Completion
2008-08-26
Completion
2008-08-26

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02229825 on ClinicalTrials.gov